Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 10:23 PM ET

Life Sciences Tools and Services

Company Overview of Davos Chemical Corporation

Company Overview

Davos Chemical Corporation provides chemistry and pharmaceutical services for biotechs and pharmaceutical companies in United States, Europe, and Asia. The company offers drug substance and drug products in the areas of preclinical/clinical supply, commercial manufacture, and cytotoxics and other compounds; documentation preparation and support services; oral and parenteral clinical trial materials; synthesized materials, including APIs and intermediates; analytical services, such as methods development, testing, and validation; preformulation and formulation development services; chemistry development and optimization services; and medicinal chemistry and biology discovery services. Davos C...

600 East Crescent Avenue

Upper Saddle River, NJ 07458

United States

Founded in 1972





Key Executives for Davos Chemical Corporation

Chief Financial Officer and Executive Vice President
Director of Import and Export Logistics
Vice President
Vice President of Chemistry
Compensation as of Fiscal Year 2015.

Davos Chemical Corporation Key Developments

AV Therapeutics Announces Collaboration with DavosPharma to Manufacture Chemotherapeutic Drug Capridine

AV Therapeutics, Inc. announced that it has entered into an agreement with DavosPharma, to assist in the Good Manufacturing Practices (GMP) synthesis of its lead drug candidate Capridine. DavosPharma is expected to complete the manufacturing of the drug in the 2nd quarter of 2014. The Company is also in the process of preparing its Investigational New Drug (IND) application for the FDA. AV Therapeutics is hopeful that it can begin its Phase I clinical trial in the 4(th) quarter. Phase I clinical trials will be managed by a consortium of hospitals including Memorial Sloan Kettering Cancer Center. This will facilitate expeditious experimental results. Capridine has been shown to have specific activity towards both hormone dependent and independent prostate cancer and minimal bone marrow toxicity in preclinical studies conducted by AV Therapeutics. If successful Capridine will be the adjuvant chemotherapeutic drug for all stages of prostate cancer. first of its kind.

Similar Private Companies By Industry

Company Name Region
Mousera, Inc. United States
Drik LLC United States
Blue Stream Laboratories, Inc. United States
Semorex Inc. United States
Syros Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Davos Chemical Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at